http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_d1b25eab1b3760ae20c23172c5b0e718
Outgoing Links
| Predicate | Object |
|---|---|
| family-name | Beck |
| name | Stephan Beck Stephan. Beck |
| given-name | Stephan Stephan. |
| organization-name | Department of Medical Genomics UCL Cancer Institute University College London London UK Herbario Nacional de Bolivia, Instituto de Ecología, Universidad Mayor de San Andrés , Bolivia Wellcome Trust Sanger Institute, Genome Campus, Hinxton, Cambridge, UK. Imperial Cancer Research Fund Department of Cancer Biology, UCL Cancer Institute, University College London, Paul O'Gorman Building, 72 Huntley Street, London WC1E 6BT, UK UCL Cancer Institute, University College London, UK 1UCL Cancer Institute, University College London, London, United Kingdom. Research Department of Cancer Biology, University College London Cancer Institute, University College London, London, United Kingdom. UCL Cancer Institute, Paul O'Gorman Building, University College London, 72 Huntley Street, London WC1E 6BT, UK Medical Genomics Group, Paul O’Gorman Building, UCL Cancer Institute, University College London, London, UK UCL Cancer Institute, University College London, London, WC1E 6BT, UK. s.beck@ucl.ac.uk. UCL Cancer Institute University College London 72 Huntley Street London WC1E 6BT UK ‡Sanger Center, Wellcome Trust Genome Campus, Hinxton, Cambridgeshire, United Kingdom ‡Laboratory of Human Sequencing/Immunogenomics, Sanger Institute, The Wellcome Trust Genome Campus, Hinxton, Cambridge, United Kingdom; 1 Medical Genomics, and 2Statistical Genomics, UCL Cancer Institute, University College London, London WC1E 6BT, UK, 3CAS-MPG Partner Institute for Computational Biology, Shanghai Institute for Biological Sciences, Shanghai 200031, China and 4Institute of Environmental Medicine, Karolinska Instytutet, 17177 Stockholm, Sweden 1University College London, London, United Kingdom. 2 The Sanger Centre, Wellcome Trust Genome Campus, Cambridge CB10 1SA, UK Wellcome Trust Sanger Institute, Hinxton Genome Campus, Cambridge CB10 1SA, UK. UCL Cancer Institute, University College London , London WC1E 6BT, UK Medical Genomics Research Group University College London, UCL Cancer Institute London UK Department of Cancer Biology, UCL Cancer Institute, University College London, London, United Kingdom UCL Cancer Institute, University College London, 72 Huntley Street, London WC1E 6BT, UK Department of Cancer Biology, Cancer Institute, UCL, London, UK Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridgeshire CB10 1HH, UK and 2UCL Cancer Institute, University College London, London WC1E 6BT, UK Medical Genomics, UCL Cancer Institute, University College London, London, U.K. Medical Genomics Group, UCL Cancer Institute, University College London, Paul O’Gorman Building, 72 Huntley Street, London WC1E 6BT, UK. UCL Cancer Institute London UK UCL Cancer Institute, University College London London United Kingdom University College London (UCL) Cancer Institute, London, United Kingdom; Ulm University and Ulm University Medical Center, Ulm, Germany. Medical Genomics, UCL Cancer Institute, University College London, London, UK Medical Genomics Group, UCL Cancer Institute, University College London , London WC1E 6BT, UK The Sanger Centre, Wellcome Trust Genome Campus, University of Cambridge, Cambridge CB10 1SA United Kindgom;; Immunology Division, Pathology Department, Cambridge CB2 1QP, United Kingdom; Department of Cancer Biology, UCL Cancer Institute, 72 Huntley Street, London, WC1E 6DD, UK Immunology Division, Department of Pathology, Tennis Court Road, Cambridge CB2 1QP, United Kingdom; Sanger Centre, Wellcome Trust Genome Campus, Hinxton, Cambridge CB10 1SA, United Kingdom; and Imperial Cancer Research Fund, Lincolns Inn Fields, Holborn, London WC2A 3PX, United Kingdom UCL Cancer Institute, University College London, London, UK; UCL Institute of Digital Health, University College London, London, UK; UCL Institute for Precision Medicine, University College London, London, UK UMR 152 Institut de Recherche pour le Développement (IRD), Université de Toulouse 3, Faculté des sciences pharmaceutiques, 31062 Toulouse, France, IIFB, Universidad Mayor San Andrés, Facultad des ciencas farmaceuticas y bioquimicas, Av. Saavedra 224, Miraflores, La Paz, Bolivia, and Herbario Nacional de Bolivia, Universidad Mayor San Andrés, Cota Cota, Calle 27, La Paz, Bolivia UCL Cancer Institute University College London London United Kingdom 1 Statistical Genomics Group, UCL Cancer Institute, University College London, London WC1E 6BT, UK, 2Department of Medicine, Unit of Computational Medicine, Centre for Molecular Medicine, Karolinska Institute, Solna 171 76, Stockholm, Sweden and 3Medical Genomics Group, UCL Cancer Institute, University College London, London WC1E 6BT, UK Medical Genomics, Paul O’Gorman Building, UCL Cancer Institute, University College London, 72 Huntley Street, London WC1E 6BT, UK; Cancer Institute, University College London, London, United Kingdom University College London Cancer Institute, University College London, London, England Medical Genomics, UCL Cancer Institute, University College London, London WC1E 6BT, UK Medical Genomics, UCL Cancer Institute University College London London UK UCL Cancer Institute, University College London, London, United Kingdom. Department of Cancer Biology, University College London Cancer Institute, University College London, London, United Kingdom; and Virtual Reality and Visualization Research Group, Bauhaus-Universität Weimar, Weimar, Germany Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, CB10 1SA, Cambridge, Hinxton, UK ‡Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridgeshire, United Kingdom |
Incoming Links
Total number of triples: 341.